Atlas Trials

Urothelial Carcinoma Bladder

44 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Urothelial Carcinoma Bladder

RecordFirmDate
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer (NCT05312671)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2022-06-27
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer (NCT05401279)RenJi Hospital2022-06-01
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05375903)UroGen Pharma Ltd.2022-06-01
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC (NCT05077709)IO Biotech2022-04-11
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (NCT05243550)UroGen Pharma Ltd.2022-03-01
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer (NCT05241340)The Methodist Hospital Research Institute2022-02-15
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) (NCT05136898)UroGen Pharma Ltd.2021-11-30
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (NCT04688931)UroGen Pharma Ltd.2021-02-19
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic (NCT04770974)University of Florence2020-12-10
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer (NCT04386746)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2020-07-29
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma (NCT04200963)Ikena Oncology2019-12-18
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (NCT03558503)UroGen Pharma Ltd.2018-10-15
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma (NCT03606174)Mirati Therapeutics Inc.2018-09-11
Phase Ib of L-NMMA and Pembrolizumab (NCT03236935)The Methodist Hospital Research Institute2018-08-27
Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer (NCT04740866)Cairo University2018-08-01
En Bloc Bladder Tumor Resection: Prospective Randomized Study (NCT04712201)Fundacio Puigvert2018-04-01
Bladder Cancer Adjuvant Radiotherapy Trial (NCT02951325)Tata Memorial Centre2016-06-02

Track Urothelial Carcinoma Bladder automatically

Every clearance here is in the API, with alerts when new ones post.